Chengdu Biocity is an investment firm.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 25, 2022
Xilingyuan Pharmaceutical
|
Series B | ¥90M | Biotechnology | — |
Nov 26, 2020
Biostar Technologies
|
Series E | $890M | Biotechnology | — |